Demand for Slimming Pills Soars

Sunday 18th September 2010

Demand for slimming pills has soared, according to newly disclosed figures which show that the NHS now spends £50 million per year on anti-obesity drugs.

The unprecedented demand for slimming aids has seen the prescriptions for Orlistat, popularly known as Alli break the million prescription mark for the first time. And data shows that £35.7 million was spent on prescribing the pill which promotes weight loss by stopping the body from absorbing fat.

The soar in prescription levels shows that slimmers are increasingly supplementing dieting with slimming aids in order to boost their weight loss results.

Fat related diseases are thought to cost the NHS in excess of £4 billion per year, whilst also leading to the deaths of an estimated 30,000 people per year.

« Latest UK Health & Medical News Weight Loss Surgery News »